Luminal A is the most common molecular subtype of breast cancer, accounting for approximately 50% of invasive breast cancer cases [2], and is characterized as estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), HER2/Neu-negative, with low Ki-67 expression [3]
Preclinical mode-of-action studies have shown that cagrilintide and closely related experimental compounds can produce additional effects when studied alongside semaglutide in diet-induced obesity models [4]
The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1
In the past, they helped humans conserve energy during famine
Therefore, the method of the present invention provides various advantages such as production of L-carnitine and acetyl L-carnitine hydrochloride with a high optical purity, environmental friendliness due to the use of immobilized lipase as an enzyme, and low production costs due to the feasibility of repeated use of enzyme
However, patients should still check about other benefits and savings